BMAP-18 is a truncated form of the antimicrobial peptide BMAP-271. Bovine myeloid antimicrobial peptide-27(BMAP-27) belongs to the Cathelicidin family of peptides which displays rapid bactericidal activity against Staphylococcus aureus, Streptococcus uberis, and Escherichia coli. BMAP-27 is cytotoxic to human erythrocytes and neutrophils, although at higher than microbicidal concentrations1-3. BMAP-18 displays much higher cell selectivity as compared to parental BMAP-27 because of their decreased hemolytic activity and retained antimicrobial activity.
1. The spatiotemporal control of signalling and trafficking of the GLP-1R
3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.